Elsevier

Bone

Volume 17, Issue 2, Supplement 1, August 1995, Pages S63-S67
Bone

Role of cytokines in bone resorption

https://doi.org/10.1016/8756-3282(95)00180-LGet rights and content

Abstract

It has been established during the past few years that interleukin(s)-1, -6, -11 (IL-1, IL-6, IL-11), and tumor necrosis factor (TNF) can stimulate osteoclast development and thereby the process of bone resorption. Moreover, upregulation of the production and/or action of IL-6 has been implicated in the pathogenesis of disease states characterized by excessive osteoclastic bone resorption, including the osteopenias associated with loss of either ovarian or testicular function. This article highlights this evidence and attempts to clarify the role of cytokines in the bone loss associated with gonadal deficiency. Specifically, it reviews data demonstrating that the protective effects of estrogens and androgens on the skeleton are mediated through their ability to inhibit IL-6 production. Both of these steroids exert their effects by inhibiting the transcriptional activity of the IL-6 gene promoter via mechanisms involving their respective specific receptors. Upon loss of gonadal function in either sex, there occurs an upregulation of osteoclast formation which is mediated by IL-6. Consistent with this, IL-6-deficient mice do not exhibit an increase in the formation of osteoclasts after ovariectomy or orchidectomy, and are protected from the bone loss caused by the loss of gonadal function in either sex. Even though these observations establish that IL-6 is an essential pathogenetic factor in the bone loss caused by gonadal deficiency, it remains unclear whether IL-6 is the sole pathogenetic factor or whether IL-1, TNF, and IL-11 may also be involved. However, in contrast to IL-6, these cytokines do not seem to be directly regulated by sex steroids. Therefore, it is unlikely that they are causative factors in the pathogenesis of this condition; yet, because they are required for osteoclast development, they may be participatory factors in the bone loss caused by gonadal deficiency.

References (45)

  • A. Demulder et al.

    Effects of stem cell factor on osteoclast-like cell formation in long-term human marrow cultures

    J Bone Miner Res

    (1992)
  • R.D. Devlin et al.

    Stimulation of osteoclast-like multinucleated cell (MNC) formation in long-term human bone marrow culture by the serum of patients with Gorham-Stout or disappearing bone disease

    J Bone Miner Res

    (1994)
  • S.G. Emerson

    The stem cell model of hematopoiesis

  • R. Felix et al.

    Role of colony-stimulating factor-1 in bone metabolism

    J Cell Biochem

    (1994)
  • H.S. Fox

    The effects of sex steroids on autoimmune disease and the immune system

  • G. Girasole et al.

    17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in-vitro: a potential mechanism for the antiosteoporotic effect of estrogens

    J Clin Invest

    (1992)
  • G. Girasole et al.

    Interleukin-11: A new cytokine critical for osteoclast development

    J Clin Invest

    (1994)
  • S.L. Greenspan et al.

    Osteoporosis in men with hyperprolactinemic hypogonadism

    Ann Intern Med

    (1986)
  • M.C. Horowitz et al.

    Colony stimulating factors and bone remodeling

  • S.K. Hu et al.

    Effect of estradiol on interleukin 1 synthesis by macrophages

    Int J Immunopharmacol

    (1988)
  • R.L. Jilka et al.

    Estrogen deficiency induces sensitivity of the osteoclastogenic process to IL-6

    J Bone Miner Res

    (1994)
  • R.L. Jilka et al.

    Increased osteoclast development after estrogen loss: Mediation by interleukin-6

    Science

    (1992)
  • Cited by (279)

    View all citing articles on Scopus
    View full text